BOSTON, Nov. 11, 2016 /PRNewswire/ -- Over the past decade, the prevalence of cirrhosis has increased by almost 40 percent among people with hepatitis C (HCV) in the United States, according to research presented at The Liver Meeting® — held by the American Association for the Study of Liver Diseases. Hepatitis C has been linked to cirrhosis (i.e., scarring of the liver), decompensated cirrhosis, and death, but the extent of the prevalence of thes...
A study that explored the healthcare burden of chronic infection of the hepatitis C virus found that patients with the disease were more than 3 times likely to be hospitalized than patients in a comparison group. Researchers analyzed data collected over seven years from the Chronic Hepatitis Cohort Study, an observational cohort of hepatitis C patients, and compared hospitalization rates with two groups of health system patients. Results of the study,
Canada's top liver physicians released new figures showing dramatically increased costs due to untreated hepatitis C which would place a great burden on our medical system over the next 20 years. Liver-related deaths due to liver cancer, liver failure and other causes due to untreated hepatitis C are projected to increase 160% over the next 20 years, significantly more than projected currently by the Public Health Agency of Canada. Treatments are availabl
The most current statistics, research, and data about hepatitis B and C, as well as other liver diseases, can be found in the recent report, Liver Disease in Canada: A Crisis in the Making: An Assessment of Liver Disease in Canada Published by the Canadian Liver Foundation in March, 2013. Dr. Morris Sherman (MB.BCh, PhD, FRCP(C)), et al. Download this ENTIRE important report in PDF format from:http://www.liver.ca/files/PDF/Liver_Disease_Report_2013/Liver_D